These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3079022

  • 1. Renal transplantation from living donors mismatched for two HLA haplotypes.
    Sødal G, Albrechtsen D, Berg KJ, Bondevik H, Brekke IB, Fauchald P, Jakobsen A, Talseth T, Thorsby E, Flatmark A.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1509-10. PubMed ID: 3079022
    [No Abstract] [Full Text] [Related]

  • 2. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors.
    Shapira Z, Zamir R, Livni E, Yussim A, Shmueli D, Yehoshua H.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596
    [No Abstract] [Full Text] [Related]

  • 3. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z, Adam K, Parapanissiou E, Sakellariou G, Papakyriazi E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract] [Full Text] [Related]

  • 4. A controlled trial of triple therapy in renal transplantation.
    Salaman JR, Griffin PJ, Ross WB, Williams JD.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract] [Full Text] [Related]

  • 5. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
    Opelz G, Schwarz V, Engelmann A, Back D, Wilk M, Keppel E.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
    [No Abstract] [Full Text] [Related]

  • 6. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
    Bakran A, Taylor GM, Read I, Fergusson W, Johnson RW.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of the "NIMA effect" in renal transplantation. Collaborative Transplant Study.
    Opelz G.
    Clin Transpl; 1990 Feb; ():63-7. PubMed ID: 2103176
    [Abstract] [Full Text] [Related]

  • 8. Early rejection following donor-specific transfusion prior to HLA-mismatched living related renal transplantation.
    Sells RA, Scott MH, Prieto M, Bone JM, Evans GM, Millar R, Hills AN.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1173-4. PubMed ID: 2650088
    [No Abstract] [Full Text] [Related]

  • 9. Renal transplantation from HLA-haploidentical living donors. Efficacy of cyclosporine in a multicenter study.
    Albrechtsen D, Flatmark A, Lundgren G, Brynger H, Frödin L, Groth C, Gäbel H, Thorsby E.
    Transplant Proc; 1987 Oct; 19(5):3579-81. PubMed ID: 2960040
    [No Abstract] [Full Text] [Related]

  • 10. The beneficial effect of cyclosporine preloading in renal transplants from HLA-haploidentical living donors.
    Hong J, Sumrani N, Delaney V, Davis R, Tejani A, Friedman EA, Butt KM.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1003-4. PubMed ID: 1989137
    [No Abstract] [Full Text] [Related]

  • 11. Steroid withdrawal in HLA-nonidentical living-related donor transplant recipients.
    Mendez R, Aswad S, Mendez RG, Cicciarelli J, Asai P, Sakhrani L, Bogaard T, Khetan U, Flores N.
    Transplant Proc; 1992 Oct; 24(5):1891-3. PubMed ID: 1412901
    [No Abstract] [Full Text] [Related]

  • 12. Zero-HLA haplotype matched siblings as living related renal donors.
    Kaufman DB, Sutherland DE, Fryd DS, Noreen H, Najarian JS.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):671-4. PubMed ID: 2650217
    [No Abstract] [Full Text] [Related]

  • 13. The use of HLA-mismatched living related donors for renal transplantation is justified by the highly successful long-term results.
    Samhan M, Abouna GM, White AG, Al-Abdulla IH, Kumar MS, Panjwani D, Philips EM, Silva OS.
    Transplant Proc; 1988 Oct; 20(5):800-1. PubMed ID: 3055503
    [No Abstract] [Full Text] [Related]

  • 14. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N, Hong JH, Daskalakis P, Cacciarelli TV, Markell MS, Sommer BG.
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract] [Full Text] [Related]

  • 15. Living-related and unrelated donor kidney transplantation: comparison between ABO-compatible and incompatible grafts.
    Reding R, Squifflet JP, Pirson Y, Jamart J, De Bruyère M, Moriau M, Latinne D, Carlier M, Alexandre GP.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1511-3. PubMed ID: 3274365
    [No Abstract] [Full Text] [Related]

  • 16. Living related donor kidney grafts in the cyclosporine era.
    MacDonald AS, Belitsky P, Bitter-Suermann H, Cohen A, Crocker J, Ogborn M.
    Transplant Proc; 1989 Apr; 21(2):3364-5. PubMed ID: 2652839
    [Abstract] [Full Text] [Related]

  • 17. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
    Isoniemi H, Eklund B, Höckerstedt K, Korsbäck C, Salmela K, von Willebrand E, Häyry P, Ahonen J.
    Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transplantation with kidney grafts from living donors mismatched for two haplotypes.
    Sødal G, Albrechtsen D, Brekke IB, Bondevik H, Fauchald P, Jakobsen A, Flatmark A.
    Transplant Proc; 1988 Jun; 20(3):377-9. PubMed ID: 3289164
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.